Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("NELSON, Jeanenne J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke A population-based cohort study from Malmö, SwedenPERSSON, Margaretha; BERGLUND, Göran; NELSON, Jeanenne J et al.Atherosclerosis. 2008, Vol 200, Num 1, pp 191-198, issn 0021-9150, 8 p.Article

Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjectsPERSSON, Margaretha; HEDBLAD, Bo; NELSON, Jeanenne J et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 6, pp 1411-1416, issn 1079-5642, 6 p.Article

Lp-PLA2 : A new kid on the blockZALEWSKI, Andrew; NELSON, Jeanenne J; HEGG, Lisa et al.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 9, pp 1645-1650, issn 0009-9147, 6 p.Article

The epidemiology of Lp-PLA2 : Distribution and correlation with cardiovascular risk factors in a population-based cohortPERSSON, Margaretha; NILSSON, Jan-Ake; NELSON, Jeanenne J et al.Atherosclerosis. 2007, Vol 190, Num 2, pp 388-396, issn 0021-9150, 9 p.Article

Cardiovascular Events With Increased Lipoprotein-Associated Phospholipase A2 and Low High-Density Lipoprotein-Cholesterol : The Veterans Affairs HDL Intervention TrialROBINS, Sander J; COLLINS, Dorothea; NELSON, Jeanenne J et al.Arteriosclerosis, thrombosis, and vascular biology. 2008, Vol 28, Num 6, pp 1172-1178, issn 1079-5642, 7 p.Article

Lipoprotein-Associated Phospholipase A2 Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 DiabetesHATOUM, Ida J; HU, Frank B; NELSON, Jeanenne J et al.Diabetes (New York, NY). 2010, Vol 59, Num 5, pp 1239-1243, issn 0012-1797, 5 p.Article

The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patientsALLISON, Matthew A; DENENBERG, Julie O; NELSON, Jeanenne J et al.Journal of vascular surgery. 2007, Vol 46, Num 3, pp 500-506, issn 0741-5214, 7 p.Article

Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)CASLAKE, Muriel J; PACKARD, Chris J; SHEPHERD, James et al.Atherosclerosis. 2010, Vol 210, Num 1, pp 28-34, issn 0021-9150, 7 p.Article

A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical dataPARKS, Daniel; XIWU LIN; PAINTER, Jeffery L et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 6, pp 571-578, issn 1053-8569, 8 p.Article

Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among womenHATOUM, Ida J; COOK, Nancy R; NELSON, Jeanenne J et al.The American heart journal. 2011, Vol 161, Num 3, pp 516-522, issn 0002-8703, 7 p.Article

β-Blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registryFRANCIOSA, Joseph A; MASSIE, Barry M; LUKAS, Mary Ann et al.The American heart journal. 2004, Vol 148, Num 4, pp 718-726, issn 0002-8703, 9 p.Article

Anti-ischemic effects and long-term survival during Ranolazine Monotherapy in Patients with chronic severe anginaCHAITMAN, Bernard R; SKETTINO, Sandra L; WOLFF, Andrew A et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 8, pp 1375-1382, issn 0735-1097, 8 p.Article

Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery diseaseHATOUM, Ida J; NELSON, Jeanenne J; COOK, Nancy R et al.The American journal of clinical nutrition. 2010, Vol 91, Num 3, pp 786-793, issn 0002-9165, 8 p.Article

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and risk of cardiovascular disease in older adults: Results from the Cardiovascular Health StudySWORDS JENNY, Nancy; SOLOMON, Cam; CUSHMAN, Mary et al.Atherosclerosis. 2010, Vol 209, Num 2, pp 528-532, issn 0021-9150, 5 p.Article

Distribution and Correlates of Lipoprotein-Associated Phospholipase A2 in an Elderly Cohort : The Cardiovascular Health StudyFURBERG, Curt D; NELSON, Jeanenne J; SOLOMON, Cam et al.Journal of the American Geriatrics Society. 2008, Vol 56, Num 5, pp 792-799, issn 0002-8614, 8 p.Article

β-Blocker dosing in community-based treatment of heart failureFOWLER, Michael B; LOTTES, Sandra R; NELSON, Jeanenne J et al.The American heart journal. 2007, Vol 153, Num 6, pp 1029-1036, issn 0002-8703, 8 p.Article

Predictors of clinical outcomes in patients given Carvedilol for heart failureGREENBERG, Barry; LOTTES, Sandra R; NELSON, Jeanenne J et al.The American journal of cardiology. 2006, Vol 98, Num 11, pp 1480-1484, issn 0002-9149, 5 p.Article

  • Page / 1